SEC Form D filing

AeroRx Therapeutics, Inc., 2025-10-10

An SEC Form D private-offering notice from La Jolla, CA, a $20,751,992 filer-stated offering target in Biotech. Filed 2025-10-10. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

AeroRx Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing nebulized combination therapies, including AERO-007, for chronic obstructive pulmonary disease (COPD).

Filed 2025-10-10Filed to raise $20,751,992First money in 2025-09-25Raised so far $10,376,003HQ (as filed) La Jolla, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified aerorxtx.com↗Named in the filing 6 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source